GGrantIndex
← Leaderboards

Nirmish R Shah

Duke University

$4,694,415
Attributed
$14,299,410
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY201524
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$13,999,411 · 5
AHRQ$299,999 · 1

By mechanism

UH3$6,352,490 · 1
U01$4,831,553 · 1
R01$1,538,852 · 1
UG3$827,226 · 1
K23$449,290 · 1
R21$299,999 · 1

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Sickle Cell Anemia

Research focus

Sickle Cell AnemiaHospitalizationPainBaseChronicCaringAcutePharmaceutical PreparationsProgramsPatient CareRandomizedPragmatic Clinical TrialIndividual PatientImproved OutcomeMedical ComplicationUnited StatesUniversitiesEventAccident And Emergency DepartmentReportingChronic DiseaseHybridsChronic PainPatient Population

Grant awards (22)

Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,584,065
UH3 · FY2024 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,582,439
UH3 · FY2023 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,573,843
UH3 · FY2022 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,612,143
UH3 · FY2021 · AT
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$654,479
U01 · FY2021 · HL
SCH: INT: Collaborative Research: Development and analysis of new mathematical and statistical models for chronic pain$270,467
R01 · FY2021 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$827,226
UG3 · FY2020 · AT
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$660,915
U01 · FY2020 · HL
SCH: INT: Collaborative Research: Development and analysis of new mathematical and statistical models for chronic pain$368,508
R01 · FY2020 · AT
SCH: INT: Collaborative Research: Development and analysis of new mathematical and statistical models for chronic pain$328,771
R01 · FY2020 · AT
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$935,730
U01 · FY2019 · HL
SCH: INT: Collaborative Research: Development and analysis of new mathematical and statistical models for chronic pain$288,299
R01 · FY2019 · AT
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$225,400
U01 · FY2019 · HL
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$942,300
U01 · FY2018 · HL
SCH: INT: Collaborative Research: Development and analysis of new mathematical and statistical models for chronic pain$282,807
R01 · FY2018 · AT
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$694,367
U01 · FY2017 · HL
Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy$157,929
K23 · FY2017 · HL · contact PI
Improving SCD Care using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina$718,362
U01 · FY2016 · HL
Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy$157,929
K23 · FY2016 · HL · contact PI
Use of Mobile Technology to Improve Acute Care Utilization in Sickle Cell Disease$149,999
R21 · FY2016 · HS · contact PI
Use of Mobile Technology to Improve Acute Care Utilization in Sickle Cell Disease$150,000
R21 · FY2015 · HS · contact PI
Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy$133,432
K23 · FY2015 · HL · contact PI